Module

Pathogenesis and Progression of Lymphoproliferative Disease: Evolving Concepts

Source: Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment

Pathogenesis and Progression of Lymphoproliferative Disease: Evolving Concepts

Program Director: Alexandra M. Levine, MD

Faculty:

Alexandra M. Levine, MD

CME CREDIT INFORMATION

Release Date: 09/11/08

Expiration Date: 09/10/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.9 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Define the unique characteristics of non-Hodgkin’s lymphomas
Recall the relevant pathophysiology of lymphoproliferative diseases when designing a treatment strategy
Cite current evidence when selecting optimal treatment for patients with non-Hodgkin’s lymphomas to improve patient outcomes and quality of life

Topics covered include:

Introduction
Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Burkitt’s Lymphoma
Diffuse Large B-Cell Lymphoma
Small Cleaved or Germinal Center Cell Lymphoma
Conclusions

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.